122 related articles for article (PubMed ID: 12595969)
1. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.
van den Ham EC; Kooman JP; Christiaans ML; van Hooff JP
Transpl Int; 2003 Feb; 16(2):82-7. PubMed ID: 12595969
[TBL] [Abstract][Full Text] [Related]
2. No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.
ter Meulen CG; van Riemsdijk I; Hené RJ; Christiaans MH; Borm GF; Corstens FH; van Gelder T; Hilbrands LB; Weimar W; Hoitsma AJ
Transplantation; 2004 Jul; 78(1):101-6. PubMed ID: 15257046
[TBL] [Abstract][Full Text] [Related]
3. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
5. The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation.
ter Meulen CG; Hilbrands LB; van den Bergh JP; Hermus AR; Hoitsma AJ
Osteoporos Int; 2005 Mar; 16(3):255-62. PubMed ID: 15232677
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
[TBL] [Abstract][Full Text] [Related]
7. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients.
Lippuner K; Casez JP; Horber FF; Jaeger P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3795-802. PubMed ID: 9814449
[TBL] [Abstract][Full Text] [Related]
8. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
Wlodarczyk Z; Walaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradszky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Kalmar KN; Hickey D
Transpl Int; 2005 Feb; 18(2):157-62. PubMed ID: 15691267
[TBL] [Abstract][Full Text] [Related]
9. High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.
Natsui K; Tanaka K; Suda M; Yasoda A; Sakuma Y; Ozasa A; Ozaki S; Nakao K
Osteoporos Int; 2006 Jan; 17(1):105-8. PubMed ID: 15886861
[TBL] [Abstract][Full Text] [Related]
10. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and body composition in patients with airflow obstruction--the role of inhaled steroid therapy, disease and lifestyle.
Lau EM; Li M; Woo J; Lai C
Clin Exp Allergy; 1998 Sep; 28(9):1066-71. PubMed ID: 9761009
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
[TBL] [Abstract][Full Text] [Related]
14. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
Howell SJ; Radford JA; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 2000 May; 52(5):609-16. PubMed ID: 10792341
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen.
Mart íG; Gómez R; Jódar E; Loinaz C; Moreno E; Hawkins E
Osteoporos Int; 2002; 13(2):147-50. PubMed ID: 11905524
[TBL] [Abstract][Full Text] [Related]
16. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F
Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation.
Rocha A; Martins LS; Malheiro J; Dores J; Santos C; Henriques C
J Bone Miner Metab; 2016 Mar; 34(2):209-15. PubMed ID: 25837429
[TBL] [Abstract][Full Text] [Related]
18. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
[TBL] [Abstract][Full Text] [Related]
19. Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.
Herrala J; Puolijoki H; Liippo K; Raitio M; Impivaara O; Tala E; Nieminen MM
Bone; 1998 May; 22(5):577-82. PubMed ID: 9600795
[TBL] [Abstract][Full Text] [Related]
20. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
